Vaccines become more attractive to drug developers

11/18/2009 | Google

Vaccines are catching up with prescription drugs as the most lucrative segment of the pharmaceutical business, as more biotech and drug firms invest in vaccine development. GlaxoSmithKline opened a vaccine-packaging plant in Pennsylvania in a bid to topple Merck & Co. as a global leader in vaccine manufacturing, while Johnson & Johnson plans to build a full vaccine portfolio that includes a universal flu shot and a vaccine for Alzheimer's disease.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD